Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA)
Crossref DOI link: https://doi.org/10.1007/s40618-015-0314-7
Published Online: 2015-05-27
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ciresi, A.
Cicciò, F.
Amato, M. C.
Giordano, C.
Text and Data Mining valid from 2015-05-27